Atlas Trials

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Clinical trial NCT06807463 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06807463
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2025-03-31
Primary completion
2026-09-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.